MarketingRx roundup: Astellas menopause drug led NFL TV spending; A podcast’s deep dive into Novo’s history

Astellas introduces menopause drug to NFL audience: Astellas spent more money advertising its menopause drug Veozah than any other new brand on regular NFL broadcasts in the 2023-2024 season so far, according to data from real-time TV ad tracker Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks